Resistant starch works as a prebiotic in the gut, aiding in upregulating GLP-1
That is the gold standard
Notably, a 2020 clinical trial involving patients with nonalcoholic steatohepatitis (NASH) revealed a 15% incidence of tumors (benign, malignant, or unspecified) (35/239) among those administered semaglutide, compared to 8% (6/80) in the control group [108]
The dose schedule outlines the standard four-week intervals used in clinical trials
Prescription medications are provided only after consultation with a physician to determine if the medication is appropriate for you
This article describes GLP-1 peptide characteristics and the mechanisms mediating its known role in increasing insulin, decreasing glucagon, delaying gastric emptying, and promoting satiety